ÂÜÀòÂÒÂ×

Dhairyarajsinh Gohil has extensive experience in the biopharmaceutical industry, currently serving as the QMS lead at Biocon Biologics since May 2022, where responsibilities include overseeing QMS activities for mammalian production of products such as trastuzumab and bevacizumab. Prior to this role, Dhairyarajsinh worked as a Manager at Reliance Industries Limited from June 2017 to May 2022, focusing on novel peptides and biosynthetic materials in the R&D facility. Earlier experience includes positions at Serum Institute of India Pvt. Ltd., where responsibilities encompassed downstream processing and production activities for Hib and MenA vaccines. Academic qualifications include a Master of Science in Biotechnology from Bharati Vidyapeeth, an MBA in Marketing from K.J.S. Education Institute, and a Bachelor of Science in Biotechnology from Deogiri College.